184 related articles for article (PubMed ID: 12848597)
1. [Evaluation of lercanidipine in the general practice setting].
Robles NR; Canelada JA; Iglesias M; Angulo E; López Acedo A; Díaz Olea E; Cidoncha F; Guerras M; Fuentes J; Garrido J; Lapie J; Peña J; Aguilar A; Hidalgo P
An Med Interna; 2003 Jun; 20(6):282-6. PubMed ID: 12848597
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of psychosomatic symptomatology in hypertensive patients treated with lercanidipine (LERCAPSICO study)].
Abellán Alemán J; Martínez García JF; Merino Sánchez J; Gil Guillén V; Latorre Hernández J; Fernández Montero F; Navarro Lima A;
An Med Interna; 2003 Jun; 20(6):287-91. PubMed ID: 12848598
[TBL] [Abstract][Full Text] [Related]
3. [Lercanidipine in diabetic patients with renal failure].
Robles NR; Pastor L; Manjón M; Ocón J; Gómez Campderá F; Herrera J; Villatoro J; Calls J; Torrijos J; Rodríguez Villareal I; Rodríguez Martínez MA; Méndez ML; Morey A; Martínez Fernández J; Marco J; Liébana A; Rincón B; Tornero F
Nefrologia; 2004; 24(4):338-43. PubMed ID: 15455493
[TBL] [Abstract][Full Text] [Related]
4. Lercanidipine in patients with chronic renal failure: the ZAFRA study.
Robles NR; Ocon J; Gomez CF; Manjon M; Pastor L; Herrera J; Villatoro J; Calls J; Torrijos J; Rodríguez VI; Rodriguez MM; Mendez ML; Morey A; Martinez FI; Marco J; Liebana A; Rincon B; Tornero F
Ren Fail; 2005; 27(1):73-80. PubMed ID: 15717638
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
6. Tolerability of high doses of lercanidipine versus high doses of other dihydropyridines in daily clinical practice: the TOLERANCE Study.
Barrios V; Escobar C; de la Figuera M; Llisterri JL; Honorato J; Segura J; Calderón A
Cardiovasc Ther; 2008; 26(1):2-9. PubMed ID: 18466416
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
[TBL] [Abstract][Full Text] [Related]
8. Lercanidipine vs lacidipine in isolated systolic hypertension.
Millar-Craig M; Shaffu B; Greenough A; Mitchell L; McDonald C
J Hum Hypertens; 2003 Nov; 17(11):799-806. PubMed ID: 14578921
[TBL] [Abstract][Full Text] [Related]
9. Effects of manidipine/delapril versus olmesartan/hydrochlorothiazide combination therapy in elderly hypertensive patients with type 2 diabetes mellitus.
Fogari R; Derosa G; Zoppi A; Rinaldi A; Preti P; Lazzari P; Mugellini A
Hypertens Res; 2008 Jan; 31(1):43-50. PubMed ID: 18360017
[TBL] [Abstract][Full Text] [Related]
10. Lercanidipine in the treatment of hypertension.
Beckey C; Lundy A; Lutfi N
Ann Pharmacother; 2007 Mar; 41(3):465-73. PubMed ID: 17341540
[TBL] [Abstract][Full Text] [Related]
11. Treatment of proteinuria with lercanidipine associated with renin-angiotensin axis-blocking drugs.
Robles NR; Romero B; de Vinuesa EG; Sánchez-Casado E; Cubero JJ
Ren Fail; 2010 Jan; 32(2):192-7. PubMed ID: 20199181
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive efficacy and tolerability of lercanidipine in daily clinical practice. The ELYPSE Study. Eficacia de Lercanidipino y su Perfil de Seguridad.
Barrios V; Navarro A; Esteras A; Luque M; Romero J; Tamargo J; Prieto L; Carrasco JL; Herranz I; Navarro-Cid J; Ruilope LM;
Blood Press; 2002; 11(2):95-100. PubMed ID: 12035878
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of lercanidipine in mild to moderate hypertension among Asians of different ethnic groups.
Chia YC; Yeoh ES; Ng CJ; Khoo EM; Chua CT
Singapore Med J; 2009 May; 50(5):500-5. PubMed ID: 19495520
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
15. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
16. Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina).
Dalla Vestra M; Pozza G; Mosca A; Grazioli V; Lapolla A; Fioretto P; Crepaldi G
Diabetes Nutr Metab; 2004 Oct; 17(5):259-66. PubMed ID: 16295047
[TBL] [Abstract][Full Text] [Related]
17. Effect of antihypertensive treatment on cardiovascular events in elderly hypertensive patients: Japan's Benidipine Research on Antihypertensive Effects in the Elderly (J-BRAVE).
Saito I; Suzuki H; Kageyama S; Saruta T
Clin Exp Hypertens; 2011; 33(2):133-40. PubMed ID: 21269056
[TBL] [Abstract][Full Text] [Related]
18. Treatment of hypertension in patients 85 years of age or older: a J-BRAVE substudy.
Saito I; Suzuki H; Kageyama S; Saruta T
Clin Exp Hypertens; 2011; 33(5):275-80. PubMed ID: 21787236
[TBL] [Abstract][Full Text] [Related]
19. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?
Burnier M; Pruijm M; Wuerzner G
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):981-7. PubMed ID: 19619074
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive efficacy of indapamide SR in hypertensive patients uncontrolled with a background therapy: the NATIVE study.
Akram J; Sheikh UE; Mahmood M; Donnelly R
Curr Med Res Opin; 2007 Dec; 23(12):2929-36. PubMed ID: 17931463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
